These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 15183429)

  • 1. Suppression of early experimental osteoarthritis by gene transfer of interleukin-1 receptor antagonist and interleukin-10.
    Zhang X; Mao Z; Yu C
    J Orthop Res; 2004 Jul; 22(4):742-50. PubMed ID: 15183429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of experimental osteoarthritis by adenovirus-mediated double gene transfer.
    Wang HJ; Yu CL; Kishi H; Motoki K; Mao ZB; Muraguchi A
    Chin Med J (Engl); 2006 Aug; 119(16):1365-73. PubMed ID: 16934183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Suppression of articular cartilage breakdown in osteoarthritis by interleukin-1 receptor antagonist using ex vivo gene therapy].
    Guo WS; Ma L; Li ZR
    Zhonghua Yi Xue Za Zhi; 2004 May; 84(10):853-6. PubMed ID: 15200893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoarthritis gene therapy.
    Evans CH; Gouze JN; Gouze E; Robbins PD; Ghivizzani SC
    Gene Ther; 2004 Feb; 11(4):379-89. PubMed ID: 14724685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene-mediated restoration of cartilage matrix by combination insulin-like growth factor-I/interleukin-1 receptor antagonist therapy.
    Nixon AJ; Haupt JL; Frisbie DD; Morisset SS; McIlwraith CW; Robbins PD; Evans CH; Ghivizzani S
    Gene Ther; 2005 Jan; 12(2):177-86. PubMed ID: 15578043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of intra-articular responses to interleukin-1 by transfer of the interleukin-1 receptor antagonist gene to synovium.
    Hung GL; Galea-Lauri J; Mueller GM; Georgescu HI; Larkin LA; Suchanek MK; Tindal MH; Robbins PD; Evans CH
    Gene Ther; 1994 Jan; 1(1):64-9. PubMed ID: 7584062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of cartilage destruction by double gene transfer of IL-1Ra and IL-10 involves the activin pathway.
    Neumann E; Judex M; Kullmann F; Grifka J; Robbins PD; Pap T; Gay RE; Evans CH; Gay S; Schölmerich J; Müller-Ladner U
    Gene Ther; 2002 Nov; 9(22):1508-19. PubMed ID: 12407423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct chitosan-mediated gene delivery to the rabbit knee joints in vitro and in vivo.
    Zhang X; Yu C; Xushi ; Zhang C; Tang T; Dai K
    Biochem Biophys Res Commun; 2006 Mar; 341(1):202-8. PubMed ID: 16413501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-articular delivery of a herpes simplex virus IL-1Ra gene vector reduces inflammation in a rabbit model of arthritis.
    Oligino T; Ghivizzani S; Wolfe D; Lechman E; Krisky D; Mi Z; Evans C; Robbins P; Glorioso J
    Gene Ther; 1999 Oct; 6(10):1713-20. PubMed ID: 10516720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo gene delivery of IL-1Ra and soluble TNF receptor confers a distal synergistic therapeutic effect in antigen-induced arthritis.
    Kim SH; Lechman ER; Kim S; Nash J; Oligino TJ; Robbins PD
    Mol Ther; 2002 Nov; 6(5):591-600. PubMed ID: 12409257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of recombinant human interleukin 1 receptor antagonist on the induction phase of antigen induced arthritis in the rabbit.
    Lewthwaite J; Blake SM; Hardingham TE; Warden PJ; Henderson B
    J Rheumatol; 1994 Mar; 21(3):467-72. PubMed ID: 8006890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of antigen-induced arthritis in rabbits by ex vivo gene therapy.
    Otani K; Nita I; Macaulay W; Georgescu HI; Robbins PD; Evans CH
    J Immunol; 1996 May; 156(9):3558-62. PubMed ID: 8617986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of experimental equine osteoarthritis by in vivo delivery of the equine interleukin-1 receptor antagonist gene.
    Frisbie DD; Ghivizzani SC; Robbins PD; Evans CH; McIlwraith CW
    Gene Ther; 2002 Jan; 9(1):12-20. PubMed ID: 11850718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual transduction of insulin-like growth factor-I and interleukin-1 receptor antagonist protein controls cartilage degradation in an osteoarthritic culture model.
    Haupt JL; Frisbie DD; McIlwraith CW; Robbins PD; Ghivizzani S; Evans CH; Nixon AJ
    J Orthop Res; 2005 Jan; 23(1):118-26. PubMed ID: 15607883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technology evaluation: MFG-IRAP, University of Pittsburgh.
    Baragi VM
    Curr Opin Mol Ther; 2000 Apr; 2(2):216-20. PubMed ID: 11249645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against collagen-induced arthritis by intramuscular gene therapy with an expression plasmid for the interleukin-1 receptor antagonist.
    Kim JM; Jeong JG; Ho SH; Hahn W; Park EJ; Kim S; Yu SS; Lee YW; Kim S
    Gene Ther; 2003 Sep; 10(18):1543-50. PubMed ID: 12907945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1 receptor antagonist inhibits proteoglycan breakdown in antigen induced but not polycation induced arthritis in the rabbit.
    Arner EC; Harris RR; DiMeo TM; Collins RC; Galbraith W
    J Rheumatol; 1995 Jul; 22(7):1338-46. PubMed ID: 7562769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer.
    Bandara G; Mueller GM; Galea-Lauri J; Tindal MH; Georgescu HI; Suchanek MK; Hung GL; Glorioso JC; Robbins PD; Evans CH
    Proc Natl Acad Sci U S A; 1993 Nov; 90(22):10764-8. PubMed ID: 8248169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo suppression of early experimental osteoarthritis by interleukin-1 receptor antagonist using gene therapy.
    Pelletier JP; Caron JP; Evans C; Robbins PD; Georgescu HI; Jovanovic D; Fernandes JC; Martel-Pelletier J
    Arthritis Rheum; 1997 Jun; 40(6):1012-9. PubMed ID: 9182910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of the inhibitory effects of interleukin-1 receptor antagonist following administration as a recombinant protein or by gene transfer.
    Gouze JN; Gouze E; Palmer GD; Liew VS; Pascher A; Betz OB; Thornhill TS; Evans CH; Grodzinsky AJ; Ghivizzani SC
    Arthritis Res Ther; 2003; 5(5):R301-9. PubMed ID: 12932294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.